Neurological Diseases

In recent decades, genetic technologies for research and diagnostics have transformed healthcare, offering new possibilities in precision medicine and disease management. Next-generation sequencing (NGS) has revolutionized genetic disease diagnostics and oncology, providing comprehensive insights at a relatively low cost. PCR continues to evolve, remaining a central tool in molecular diagnostics. In situ hybridization techniques (ISH)…

For further details and to purchase directly, please contact us.

The genetic involvement in the pathogenesis of neurological diseases is profound, with central nervous system disorders accounting for about 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases. Neurological diseases, especially brain diseases, represent the final frontier in medical discovery. Advances in testing, such as next-generation sequencing (NGS), have been instrumental in…

Biomarkers are biological or biochemical molecules, genetic changes, or other measurable characteristics that indicate or predict a condition, risk, or likely biological response. They have a wide range of diagnostic applications, including predicting disease risk, diagnosis, prognosis, identifying appropriate therapy, and monitoring disease or its recurrence.

Kalorama Information’s World Market for Biomarkers (Cardiac [cTn, HscTn,…